Location History:
- Lafayette, IN (US) (2014)
- West Lafayette, IN (US) (2015 - 2016)
- San Francisco, CA (US) (2018 - 2024)
Company Filing History:
3 out of 2,660 
1 out of 2 
1 out of 1 Years Active: 2014-2024
Title: Katherine Allison Stuart: Innovator in Bioconjugate Technology
Introduction
Katherine Allison Stuart is a trailblazing inventor based in San Francisco, California. With five patents to her name, she has made significant contributions to the field of bioconjugate technology, particularly focusing on collagen-binding synthetic peptides and their applications.
Latest Patents
Her latest innovations include:
1. **Bioconjugates with Chemically Modified Backbones**: This patent involves the development of synthetic bioconjugates that consist of collagen-binding peptides covalently attached to chemically modified glycan backbones. These advancements hold promising implications for various biomedical applications.
2. **Collagen-Binding Synthetic Peptidoglycans, Preparation, and Methods of Use**: This invention pertains to collagen-binding synthetic peptidoglycans, including engineered collagen matrices. It addresses the integration of such compounds in collagen matrices, enhancing their properties and functions. The patent also covers kits, compounds, compositions, and engineered graft constructs that utilize these synthetic peptidoglycans, as well as methods for their preparation and application.
Career Highlights
Katherine has worked at reputable institutions, notably the Purdue Research Foundation and Symic IP, LLC. Her tenure at these organizations has allowed her to apply her innovative ideas in practical settings, bridging the gap between research and commercialization.
Collaborations
Throughout her career, Katherine has collaborated with esteemed colleagues, including John Eric Paderi and Alyssa Panitch. These partnerships exemplify her commitment to combining expertise and knowledge in order to drive further innovation in her field.
Conclusion
Katherine Allison Stuart has established herself as a prominent inventor in the realm of bioconjugates, with key developments that promise to advance medical science. Her patents reflect a deep understanding of synthetic biology and its potential applications, making her a significant figure in contemporary innovation.